A carregar...
Bumetanide for autism: Open‐label trial in six children
AIM: Bumetanide, a diuretic agent, that reduces intracellular chloride—thereby reinforcing GABAergic inhibition—has been reported to improve core symptoms of autism in children. Given the positive results reported from French trials of bumetanide in children with autism, we decided to evaluate its e...
Na minha lista:
| Publicado no: | Acta Paediatr |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248373/ https://ncbi.nlm.nih.gov/pubmed/33336381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apa.15723 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|